Method for measuring a biomarker in a biological sample of an IPAF patient
Abstract:
Disclosed is a method for measuring a biomarker in a biological sample of the IPAF patient, wherein the biomarker comprises at least one selected from the group consisting of CXCL9 and CXCL10, and a measurement result of the biomarker is used as an index for determining treatment responsiveness to anti-inflammatory therapy.
Information query
Patent Agency Ranking
0/0